Home / Import refusals / AEK-9687524-8/10002/1

FDA Import Refusal AEK-9687524-8/10002/1 — Intas Pharmaceuticals Limited

Intas Pharmaceuticals Limited — FEI 3014639576

The FDA refused shipment AEK-9687524-8/10002/1 from Intas Pharmaceuticals Limited (India) on September 16, 2026. The refused product falls under Drugs and Biologics — NAPROXEN (ANTI-INFLAMMATORY). Cited charges: 118,75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
September 16, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
62GDA49 NAPROXEN (ANTI-INFLAMMATORY)
Charges
118,75

Other import refusals

  • AEK-9837718-5/50002/1 (Thu Sep 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9837718-5/10002/1 (Thu Sep 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9888971-8/10003/1 (Wed Sep 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-0957368-3/30002/1 (Fri Sep 18 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9615283-8/30002/1 (Tue Aug 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources